Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 31 December 2025

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

NEW YORK, December 31, 2025, 10:33 ET — Regular session Shares of Arcutis Biotherapeutics Inc rose 3.8% to $29.16 by 10:33 a.m. ET on Wednesday, extending gains in the final U.S. trading session of 2025. The Nasdaq-listed dermatology drugmaker traded between $28.08 and $29.19, with about 181,000 shares changing hands. The move puts ARQT within striking distance of $30 and about 8% below its 52-week high of $31.75, a level closely watched by momentum investors. The stock’s 52-week low stands at $11.14, according to market data. markets.businessinsider.com That relative strength mattered on a down day for risk assets. The biotech
31 December 2025
··
DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

Trump Media shares rose 4% to $13.05 Wednesday after announcing a digital token for shareholders, developed with Crypto.com. Each shareholder will be eligible for one non-cash, potentially non-transferable token per share, with rewards tied to Truth Social products. The announcement followed the launch of five Truth Social-branded ETFs on the NYSE a day earlier.
31 December 2025
···
FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

FTAI Aviation shares fell 0.5% to $196.72 premarket after launching FTAI Power, a unit converting CFM56 jet engines into 25-megawatt turbines for data centers. The company expects production to start in 2026, aiming to deliver over 100 turbines per year. The stock had surged 14.4% in the previous session. Jefferies said the platform could become a major earnings driver if scaled.
31 December 2025
··
Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

Ultragenyx shares slipped 0.2% to $22.74 premarket Wednesday after plunging 43.5% Monday on failed Phase 3 trial results for setrusumab in osteogenesis imperfecta. The company said it will cut expenses and shift focus to its DTX401 gene therapy, for which it completed a rolling FDA application. Senior VP Theodore Huizenga sold 85 shares on Dec. 29 to cover taxes. Investors await further details on cost reductions and regulatory milestones.
31 December 2025
·
Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

NEW YORK, December 31, 2025, 08:41 ET — Premarket Ambev S.A. shares were down 0.8% at $2.461 in premarket trading, after ending Tuesday up 2.5% at $2.48. The ADR has traded between $2.28 and $2.60 in recent sessions, reflecting choppy year-end positioning. StockAnalysis The timing matters because late-December trading can amplify small flows, especially in high-yield stocks where investors are repositioning around payouts. For Ambev, the week’s dividend schedule has been the main company-specific marker on screens. Ambev told investors in a U.S. securities filing that its board approved dividends of 0.4612 reais per share, “to be made on December
31 December 2025
·
Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Applied Digital shares rose about 1% to $24.31 premarket Wednesday after a non-binding term sheet proposed combining its cloud unit with Ekso Bionics to form ChronoScale. Applied Digital would own 97% of the new company if the deal closes, expected in the first half of 2026. Investors await further deal details and the Jan. 7 earnings report. The stock closed Tuesday at $24.08, down 2.9%.
31 December 2025
····
B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

B2Gold shares edged up 0.1% to $4.56 in premarket trading Wednesday, tracking a 0.9% drop in spot gold as profit-taking and higher futures margins weighed on bullion. Gold remains up about 65% for the year. B2Gold reported third-quarter production of 254,369 ounces and all-in sustaining costs of $1,479 per ounce. U.S. markets faced thin holiday trading and lower index futures ahead of the final 2025 session.
31 December 2025
··
Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour shares hovered near $5 premarket Wednesday after Fairfax Financial disclosed it bought about 15.7 million shares across two classes in late December. Fairfax and affiliates now own over 30 million Class A shares, or 16.1% of that class. The purchases totaled roughly $71 million at prices between $4.36 and $4.73. Investors await Under Armour’s next quarterly update in early 2026.
31 December 2025
··
BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

BigBear.ai shares fell 3.2% to $5.50 in premarket trading after the company postponed a shareholder vote on doubling its authorized common stock to Jan. 22. CEO Kevin McAleenan told investors the company is running low on authorized shares. The board is seeking more support for the proposal, which would raise the limit to 1 billion shares. The Ask Sage acquisition is expected to close late Q4 2025 or early Q1 2026.
31 December 2025
·
Rocket Lab (RKLB) stock ticks up in premarket as insider sale hits tape — what investors watch next

Rocket Lab (RKLB) stock ticks up in premarket as insider sale hits tape — what investors watch next

Rocket Lab shares rose 0.9% to $71.07 in premarket trading Wednesday after closing at $70.45 Tuesday. Director Edward H. Frank sold 2,500 shares at $77.39 and gifted 5,000 shares, according to an SEC filing. The company recently won an $816 million U.S. Space Development Agency contract for 18 missile-tracking satellites. Rocket Lab completed its final 2025 launch on Dec. 21, deploying a Japanese satellite.
31 December 2025
·
BitMine Immersion (BMNR) Stock Today: Ether Treasury Update Keeps Shares in Focus Ahead of Jan. 15 Vote

BitMine Immersion (BMNR) Stock Today: Ether Treasury Update Keeps Shares in Focus Ahead of Jan. 15 Vote

NEW YORK, December 31, 2025, 08:00 ET — Premarket BitMine Immersion Technologies Inc shares were little changed in premarket trading on Wednesday, keeping the crypto-treasury stock in focus after the company disclosed a larger ether position and urged shareholders to vote ahead of its annual meeting. The update matters now because BitMine has become a high-beta proxy for ether — meaning its equity can swing sharply with moves in the underlying token as investors try to price the company’s crypto-heavy balance sheet. It also comes during a year-end window when liquidity can thin and tax-driven positioning can amplify moves in
31 December 2025
··
1 … 547 548 549 550 551 … 1,172

Stock Market Today

Agricultural Bank of China 601288 A-shares slide as tech rout bites; inflation data is the next test

Agricultural Bank of China 601288 A-shares slide as tech rout bites; inflation data is the next test

7 February 2026
Agricultural Bank of China’s A shares closed down 0.45% at 6.67 yuan in Shanghai Friday, with turnover at 2.24 billion yuan. The bank’s A-share capital remained unchanged at 319.24 billion shares as of Jan. 31. Mainland and Hong Kong stocks fell after a global tech selloff and a sharp drop in silver futures. China’s January CPI data is due Feb. 11, with trading expected to thin ahead of the Lunar New Year break.
Palantir stock price rebounds after AI shakeout — what traders watch next week

Palantir stock price rebounds after AI shakeout — what traders watch next week

7 February 2026
Palantir Technologies shares rose 4.5% to $135.90 Friday after reporting a 70% jump in Q4 revenue to $1.407 billion and forecasting 61% revenue growth in 2026. The stock rebounded from a 6.8% drop Thursday, triggered by concerns over Big Tech capital spending and AI’s impact on software demand. A new partnership with Cognizant and U.S. government policy shifts kept Palantir in focus. Director Alexander D. Moore sold 20,000 shares on Feb. 2.
Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Go toTop